We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$7.49B
AUM Growth
+$381M
Cap. Flow
-$168M
Cap. Flow %
-2.25%
Top 10 Hldgs %
11.97%
Holding
386
New
15
Increased
64
Reduced
279
Closed
9

Sector Composition

Rank Sector Weight
1 Industrials 16.68%
2 Technology 15.03%
3 Healthcare 13.83%
4 Financials 13.24%
5 Consumer Discretionary 13.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPLG
251
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$4.51M 0.06%
422,431
-27,050
-6% -$273K
BPFH
252
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$4.48M 0.06%
372,580
-23,908
-6% -$277K
EAF icon
253
GrafTech
EAF
$206M
$4.42M 0.06%
38,055
-2,428
-6% -$305K
KEM
254
DELISTED
KEMET Corporation
KEM
$4.4M 0.06%
162,619
-84,690
-34% -$2.06M
INDA icon
255
iShares MSCI India ETF
INDA
$6.6B
$4.37M 0.06%
124,276
GNRC icon
256
Generac Holdings
GNRC
$12.7B
$4.35M 0.06%
43,272
-19,417
-31% -$1.81M
PKE icon
257
Park Aerospace
PKE
$815M
$4.33M 0.06%
266,078
-17,058
-6% -$282K
FMBH icon
258
First Mid Bancshares
FMBH
$1.37B
$4.28M 0.06%
121,418
-7,888
-6% -$276K
LMAT icon
259
LeMaitre Vascular
LMAT
$1.89B
$4.26M 0.06%
118,417
-7,592
-6% -$262K
KNX icon
260
Knight Transportation
KNX
$11.2B
$4.21M 0.06%
117,415
-6,002
-5% -$220K
PSMT icon
261
Pricesmart
PSMT
$5.33B
$4.13M 0.06%
58,152
-2,377
-4% -$171K
PTLA
262
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.05M 0.05%
169,553
-8,216
-5% -$227K
PS
263
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$3.99M 0.05%
+231,894
New +$3.95M
DVY icon
264
iShares Select Dividend ETF
DVY
$23.7B
$3.57M 0.05%
33,805
+32,997
+4,084% +$3.4M
LIND icon
265
Lindblad Expeditions
LIND
$2.15B
$3.55M 0.05%
216,973
-13,870
-6% -$222K
LXFR icon
266
Luxfer Holdings
LXFR
$457M
$3.31M 0.04%
179,110
-11,478
-6% -$198K
EPI icon
267
WisdomTree India Earnings Fund ETF
EPI
$2.05B
$3.1M 0.04%
124,700
+64,300
+106% +$1.56M
HTHT icon
268
Huazhu Hotels Group
HTHT
$12.8B
$3M 0.04%
74,996
+27,313
+57% +$986K
TAL icon
269
TAL Education Group
TAL
$6.75B
$2.96M 0.04%
61,425
+46,050
+300% +$1.98M
JELD icon
270
JELD-WEN Holding
JELD
$164M
$2.72M 0.04%
116,109
-6,149
-5% -$127K
TVTX icon
271
Travere Therapeutics
TVTX
$5.68B
$2.7M 0.04%
190,386
-14,103
-7% -$180K
DY icon
272
Dycom Industries
DY
$12.1B
$2.26M 0.03%
47,850
-3,472
-7% -$169K
HRTG icon
273
Heritage Insurance Holdings
HRTG
$957M
$2.22M 0.03%
167,275
-12,052
-7% -$166K
KMB icon
274
Kimberly-Clark
KMB
$36.1B
$2.08M 0.03%
15,088
+2,616
+21% +$354K
BKNG icon
275
Booking.com
BKNG
$160B
$1.99M 0.03%
24,250
+9,025
+59% +$709K

Similar funds

GW&K Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, GW&K Investment Management held 386 positions worth $7.49B, up 5.4% from $7.11B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GW&K Investment Management's Q4 2019 filing shows 15 new, 64 increased, 279 reduced and 9 closed positions. Its largest new stake was Veracyte: 1,020,082 shares worth $28.5M. The largest sale was Cambrex Corporation, an estimated $27.1M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • GW&K Investment Management's largest Q4 2019 buy was Veracyte: 1,020,082 shares worth $28.5M.
  • GW&K Investment Management added most to Ollie's Bargain Outlet in Q4 2019, an estimated $23.3M increase.
  • GW&K Investment Management's biggest Q4 2019 reduction was TSMC, cutting an estimated $25.2M.
  • GW&K Investment Management fully exited Cambrex Corporation in Q4 2019, selling an estimated $27.1M.
  • GW&K Investment Management's ten largest holdings make up 12% of its $7.49B portfolio in Q4 2019.
  • GW&K Investment Management opened 15 new positions and closed 9 in Q4 2019.
  • GW&K Investment Management's portfolio value rose 5.4% quarter-over-quarter to $7.49B.

Based on GW&K Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.